卢群,梁潇,白玲,朱丹军,薛小临,韩克

• 1:西安交通大学第一附属医院心血管内科

摘要(Abstract)：

心脏收缩力调节器（CCM）作为救治慢性射血分数降低的心力衰竭（HFrEF）的新型植入性电子治疗装置，因可增强心室肌收缩力、改善患者症状体征和心功能指标甚至远期预后，已迅速成为心血管领域倍受关注的热点。本文综述了CCM治疗HFrEF的机制和临床研究，并根据其机制和信号传递算法对其在射血分数保留的心力衰竭（HFpEF）、心脏再同步化治疗（CRT）反应不佳、合并心房颤动的HFrEF患者中的疗效进一步分析和展望，以期推动CCM可以满足更多、不同临床情况的心力衰竭患者的需求。

关键词(KeyWords)： 心脏收缩力调节器;射血分数降低的心力衰竭;机制研究;临床研究

Abstract:

Keywords:

基金项目(Foundation): 陕西省科技惠民计划项目（2016HM-04）;; 陕西省重点研发项目（2020GXLH-Y-015）;; 国家自然科学基金项目（8210021403）

作者(Author): 卢群,梁潇,白玲,朱丹军,薛小临,韩克

参考文献(References)：

• [1] McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)With the special contribution of the Heart Failure Association(HFA)of the ESC[J]. Rev Esp Cardiol(Engl Ed), 2022, 75(6):523. DOI:10.1016/j.rec.2022.05.005.
• [2] Masarone D, Kittleson MM, De Vivo S, et al. The effects of device-based cardiac contractility modulation therapy on left ventricle global longitudinal strain and myocardial mechanoenergetic efficiency in patients with heart failure with reduced ejection fraction[J]. J Clin Med, 2022,11(19):5866.DOI:10.3390/jcm11195866.
• [3] Scara A, PalamàZ, Robles AG, et al. Non-pharmacological treatment of heart failure-from physical activity to electrical therapies:a literature review[J]. J Cardiovasc Dev Dis,2024, 11(4):122. DOI:10.3390/jcdd11040122.
• [4] Wood EH,Heppner RL,Weidmann S. Inotropic effects of electric currents.Ⅰ. Positive and negative effects of constant electric currents or current pulses applied during cardiac action potentials.Ⅱ. Hypotheses:calcium movements,excitationcontraction coupling and inotropic effects[J]. Circ Res,1969,24(3):409-445. DOI:10.1161/01.res.24.3.409.
• [5] Borggrefe M, Mann DL. Cardiac contractility modulation in 2018[J]. Circulation, 2018, 138(24):2738-2740.DOI:10.1161/CIRCULATIONAHA.118.036460.
• [6] Butter C, Wellnhofer E, Schlegl M, et al.Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption[J]. J Card Fail, 2007, 13(2):137-142. DOI:10.1016/j.cardfail.2006.11.004.
• [7] Lyasnikova E, Sukhareva K, Vander M, et al.Molecular effects of cardiac contractility modulation in patients with heart failure of ischemic aetiology uncovered by transcriptome analysis[J]. Front Cardiovasc Med, 2024, 11:1321005. DOI:10.3389/fcvm.2024.1321005.
• [8] Masarone D, Kittleson MM,D’Onofrio A,et al. Basic science of cardiac contractility modulation therapy:molecular and electrophysiological mechanisms[J]. Heart Rhythm, 2024,21(1):82-88. DOI:10.1016/j.hrthm.2023.09.021.
• [9] Barnes A, Campbell C, Weiss R, et al. Cardiac contractility modulation in heart failure:mechanisms and clinical evidence[J]. Curr Treat Options Cardiovasc Med, 2020, 22(11):43. DOI:10.1007/s11936-020-00852-8.
• [10] Brunckhorst CB, Shemer I, Mika Y, et al. Cardiac contractility modulation by non-excitatory currents:Studies in isolated cardiac muscle[J]. Eur J Heart Fail, 2006, 8(1):7-15. DOI:10.1016/j.ejheart.2005.05.011.
• [11] Mohri S,Shimizu J,Mika Y,et al. Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart[J]. Am J Physiol Heart Circ Physiol,2003,284(4):H1119-H1123. DOI:10.1152/ajpheart.00378.2002.
• [12] Gupta RC, Mishra S, Wang MJ, et al. Cardiac contractility modulation electrical signals normalize activity, expression,and phosphorylation of the Na+-Ca2+exchanger in heart failure[J]. J Card Fail, 2009,15(1):48-56. DOI:10.1016/j.cardfail.2008.08.011.
• [13] Blank M, Goodman R. Initial interactions in electromagnetic field-induced biosynthesis[J]. J Cell Physiol, 2004, 199(3):359-363. DOI:10.1002/jcp.20004.
• [14] Morita H, Suzuki G, Haddad W, et al. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure[J]. J Card Fail, 2003,9(1):69-75. DOI:10.1054/jcaf.2003.8.
• [15] Morita H, Suzuki G, Haddad W, et al. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs[J]. Eur J Heart Fail, 2004, 6(2):145-150. DOI:10.1016/j.ejheart.2003.11.001.
• [16] Imai M, Rastogi S, Gupta RC, et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure[J].J Am Coll Cardiol, 2007, 49(21):2120-2128. DOI:10.1016/j.jacc.2006.10.082.
• [17] Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure[J]. J Am Coll Cardiol, 2008,51(18):1784-1789. DOI:10.1016/j.jacc.2008.01.036.
• [18] Zhang FF, Liu LT, Xie YT, et al. Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway[J]. Open Med(Wars), 2022, 17(1):365-374. DOI:10.1515/med-2022-0415.
• [19] Rastogi S, Mishra S, ZacàV, et al. Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure[J]. Cardiology, 2008, 110(4):230-237.DOI:10.1159/000112405.
• [20] Tsch?pe C, Kherad B, Klein O, et al. Cardiac contractility modulation:mechanisms of action in heart failure with reduced ejection fraction and beyond[J]. Eur J Heart Fail, 2019, 21(1):14-22. DOI:10.1002/ejhf.1349.
• [21] Stix G, Borggrefe M, Wolpert C, et al. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure[J].Eur Heart J, 2004, 25(8):650-655. DOI:10.1016/j.ehj.2004.02.027.
• [22] Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure[J]. Eur Heart J, 2008, 29(8):1019-1028. DOI:10.1093/eurheartj/ehn020.
• [23] Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure[J]. Am Heart J, 2011, 161(2):329-337.e1-2. DOI:10.1016/j.ahj.2010.10.025.
• [24] Abraham WT, Kuck KH, Goldsmith RL, et al. A Randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation[J]. JACC Heart Fail, 2018, 6(10):874-883. DOI:10.1016/j.jchf.2018.04.010.
• [25] Wiegn P, Chan R, Jost C, et al. Safety, performance,and e fficacy of cardiac contractility modulation delivered by the2-lead optimizer smart system:the FIX-HF-5C2 study[J].Circ Heart Fail, 2020, 13(4):e006512. DOI:10.1161/CIRCHEARTFAILURE.119.006512.
• [26] Schau T,Seifert M,Meyh?fer J,et al. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure[J]. Europace,2011,13(10):1436-1444. DOI:10.1093/europace/eur153.
• [27] Kuschyk J, Falk P, Demming T, et al. Long-term clinical experience with cardiac contractility modulation therapy delivered by the optimizer smart system[J]. Eur J Heart Fail, 2021,23(7):1160-1169. DOI:10.1002/ejhf.2202.
• [28] Kloppe A,Lawo T,Mijic D,et al. Long-term survival with Cardiac Contractility Modulation in patients with NYHAⅡor III symptoms and normal QRS duration.Int J Cardiol. 2016;15:209:291-5. DOI:10.1016/j.ijcard.2016.02.001.
• [29] Cappannoli L, Scacciavillani R, Rocco E, et al. Cardiac contractility modulation for patient with refractory heart failure:an updated evidence-based review[J]. Heart Fail Rev, 2021,26(2):227-235. DOI:10.1007/s10741-020-10030-4.
• [30] Riccardi M,Sammartino AM,Adamo M,et al. Cardiac contractility modulation:an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?[J]. Heart Fail Rev, 2023, 28(5):1141-1149. DOI:10.1007/s10741-023-10315-4.
• [31] Salah HM, Levin AP, Fudim M. Device therapy for heart failure with preserved ejection fraction[J].Cardiol Clin,2022, 40(4):507-515. DOI:10.1016/j.ccl.2022.06.005.
• [32] Linde C, Grabowski M, Ponikowski P, et al.Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction:a pilot study(CCM-HFpEF)[J]. Eur J Heart Fail, 2022, 24(12):2275-2284. DOI:10.1002/ejhf.2619.
• [33] Fang L, Ma Y, Wu Y, et al. Use of cardiac contractility modulation combined with left bundle branch pacing CRT-P in a female with a 22-year history of non-ischemic dilated cardiomyopathy:a case report[J]. Echocardiography,2024, 41(3):e15762. DOI:10.1111/echo.15762.
• [34] Yao J, Gao J, Yan JF, et al. Cardiac contractility modulation and subcutaneous defibrillator(S-ICD):first experience with simultaneous implantation[J].Pacing Clin Electrophysiol, 2023, 46(12):1595-1598. DOI:10.1111/pace.14695.